March 26, 2015
When stocks were hit with a hard left jab on Wednesday, techs and biotechs took the brunt of the impact. The Nasdaq Composite fell 2.4%, its first loss of greater than 2%+ since October.If you have... Continue Reading »
March 19, 2015
Equities pulled out of a steep dive in the middle of the Wednesday session, then turned up and shot higher after the Federal Reserve announced it would stop being patient, but wouldn’t be... Continue Reading »
March 12, 2015
It’s a bird, it’s a plane — it’s Super-Dollar, soaring higher into the investment stratosphere and rattling the cages of U.S. multinationals with its sonic booms.The damage is getting serious:... Continue Reading »
March 27, 2015
Stocks finally halted their four-day decline on Friday, with each of the major indexes up about 0.2% on the day, though they remained down more than 2% for the week.
Health care, consumer stocks and utilities outperformed today; meanwhile, energy stocks took it on the chin amid a fresh sell-off in crude oil. On the policy beat, Fed Chair Janet Yellen gave a speech underlining the cautious tone of previous announcements, saying that the Fed will take a 'gradualist approach' to interest-rate hikes.
In today's Trader's Advantage, I'll update you on the current holdings in our Buy List, and I am recommending a new bearish trade as well.Continue Reading »
March 26, 2015
Stocks fell again on Thursday, gapping down at the open before staging a brief recovery in the mid-afternoon -- but ultimately slipping back below the flatline in the last stretch of trading.
Most of Wall Street's attention today focused on continued geopolitical tensions, better-than-expected U.S. jobless claims and more Fedspeak. Among the key S&P sectors, telecom and tech stocks outperformed, while utilities and consumer discretionary led the way lower.
In today's Trader's Advantage, we closed three more positions today; I'll review each of those results, then update you on the remaining holdings in our Buy List.Continue Reading »
March 25, 2015
Stocks were hit with a hard left jab on Wednesday, with the techs and biotechs of the Nasdaq Composite taking the brunt of the impact.
The Nasdaq fell 2.4%, its first loss of more than 2% since October of last year. Yet if you have been trading longer than nine months, then of course you know that it is not terribly uncommon for the four-letter index to suffer a big single-day wallop.
Bespoke Investment Group, which has some of the best data analysts in the business, took a look at all prior 2%-plus declines for the Nasdaq during the current bull market (which began in March 2009) to see if they could offer some insights on what to do next. And, as usual, they came up with some useful patterns and recommendations.
In today's Trader's Advantage, I'll take a closer look at the Bespoke findings and their implications. Then I'll recap two positions we closed today and share my latest recommendations for our remaining positions.Continue Reading »
Which of the following sectors of the market do you think will outperform for the balance of 2014?
What Subscribers Are Saying